- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05107401
Crowdsourcing to Reduce HIV Stigma Among Adolescents and Young Adults in Kazakhstan
Reducing HIV Stigma to Increase HIV Testing Among Adolescents and Young Adults in Kazakhstan Using a Crowdsourcing Approach
This project will assess whether a digital crowdsourced intervention can reduce HIV stigma and promote HIV self-testing among adolescents and young adults (AYA). NIH has emphasized the need for research on interventions to reduce HIV-associated stigma and its impact on the prevention and treatment of HIV/AIDS, particularly in low and middle income countries (LMICs). The proposed study has the highest public health significance: it uses a community-based participatory approach to engage local AYA to develop a digital crowdsourced HIV stigma reduction and self-testing intervention to reduce HIV stigma and increase HIV testing.
Study Aim 1: To develop a crowdsourced digital HIV stigma reduction and self-testing intervention targeting AYA in Kazakhstan. Using a community-based participatory approach that engages local adolescents and young adults (AYA) and youth organizations, we will launch a national crowdsourcing contest in which AYA will design multimedia content to reduce HIV stigma in order to promote HIV testing among peers.
Study Aim 2: To pilot test this crowdsourced HIV stigma reduction and self-testing intervention in a preliminary efficacy trial. We will assess the intervention's feasibility and acceptability and obtain preliminary estimates of its effects on decreasing HIV stigma (primary outcome) and increasing HIV testing (secondary outcome) among AYA in Kazakhstan who received the intervention compared to individuals who did not. Participants (n=168) will be randomized 1:1 to: 1) receive the winning multimedia crowdsourced HIV stigma reduction content and a link for HIV self-testing, or 2) receive standard Kazakhstan Ministry of Health HIV informational materials and a link for HIV self-testing.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Almaty, Kazakhstan, 050040
- Columbia University Global Health Research Center of Central Asia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 16-24
- Report previous sex with another individual
- Reside in Kazakhstan
Exclusion Criteria:
- Not willing to provide consent or not able to understand study procedures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Crowdsourced Intervention
The digital crowdsourced intervention will be presented to participants in the intervention arm.
|
Adolescents and young adults will participate in a crowdsourcing contest to create digital materials to reduce HIV stigma in order to increase HIV testing.
Entries will be judged by a community judging panel and expert judging panel.
Winning entries will be selected for the digital intervention and presented to participants in the intervention arm.
|
|
No Intervention: Standard of Care
Standard HIV informational materials currently used by the Kazakhstan Ministry of Health will be presented to participants in the control arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Score Change in Total HIV Stigma Scale
Time Frame: Baseline and 3 months
|
The scale/questionnaire is comprised of 17 items on a 5-point Likert scale (score range from 17-85).
Higher scores indicate higher levels of stigma.
Outcome will be assessed in mean score change from baseline to 3 months follow-up.
|
Baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change in Perceived HIV Test Stigma
Time Frame: Baseline and 3 months
|
This is a subscale of the Total HIV Stigma scale.
It contains 2 items, each on a 1-5 point Likert scale, with a range of 5-10.
Higher values indicate higher levels of HIV stigma.
|
Baseline and 3 months
|
|
Mean Change in Perceived HIV Healthcare Stigma Subscale
Time Frame: Baseline and 3 months
|
This is a subscale of the Total HIV Stigma Scale.
It contains two items, each on a 1-5 point Likert scale, with a range of 5-10.
Higher values indicate higher levels of HIV healthcare stigma.
|
Baseline and 3 months
|
|
Mean Change in Fear & Judgement HIV Stigma Sub-scale
Time Frame: Baseline and 3 months
|
This is a subscale of the Total HIV Stigma Scale.
It consists of 5 items, each on a 1-5 point Likert scale, with a range of 5-25.
Higher values indicate higher levels of fear & judgement HIV stigma.
|
Baseline and 3 months
|
|
Mean Change in Perceived Community HIV Stigma Subscale
Time Frame: Baseline and 3 months
|
This is a subscale of the Total HIV Stigma Scale.
It consists of 8 items, each on a 1-5 point Likert-scale, with a range of 6-40.
Higher values indicate higher levels of perceived community HIV stigma.
|
Baseline and 3 months
|
|
Uptake of HIV Self-test
Time Frame: After baseline and by the 3 month follow-up period
|
The number of participants who ordered an HIV self-test kit after baseline and by the 3-month follow-up.
It is a dichotomous outcome (yes/no).
|
After baseline and by the 3 month follow-up period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alissa Davis, PhD, Columbia University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AAAT7871
- R21TW012017 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Testing
-
Universidad Peruana Cayetano HerediaCompleted
-
New York UniversityCompletedHIV TestingUnited States
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
State University of New York at BuffaloYale University Center for Interdisciplinary Research on AIDSNot yet recruitingHIV Prevention | HIV Testing | Sexual and Reproductive HealthUnited States
-
New York Blood CenterTerminated
-
University of South CarolinaDuke University; Kilimanjaro Christian Medical Centre, TanzaniaCompletedHIV TestingUnited States, Tanzania
-
Universidad Peruana Cayetano HerediaNational Institutes of Health (NIH); NGO Via LibreCompleted
-
Catholic Relief ServicesCenters for Disease Control and PreventionCompleted
-
Catholic Relief ServicesCenters for Disease Control and PreventionCompleted
Clinical Trials on Digital Crowdsourced Intervention to Reduce HIV Stigma among Adolescents and Young Adults
-
University of ChileMinistry of Health, ChileCompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderChile
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Peking UniversityCompleted
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted